Project Innovation is a consortium led by the National Patient Advocate Foundation to raise public awareness about the need to accelerate the delivery of new treatments to patients.
Project Innovation is a consortium led by the National Patient Advocate Foundation to raise public awareness about the need to accelerate the delivery of new treatments to patients.
It is an initiative supported by a national coalition of healthcare organizations to reduce the regulatory and logistical obstacles that delay drug development, encourage a new wave of experimentation through research funding, and enhance the delivery of innovation through improved communication and coordination between providers and patients.
"Patients need to understand the importance and safety of doing clinical trials," explains Charles Balch, director of the Johns Hopkins Clinical Research Network. "The standard treatment of today was actually someone's clinical research of yesterday."
Traditional Definition of ‘High-Risk’ in Patients With CLL and SLL Outdated, Needs to be Revisited
December 7th 2020In an interview with CURE®, Dr. Jan A. Burger discusses how the results of two phase 3 studies could help redefine what constitutes as low or high risk in patients with CLL or SLL.
Read More
To gain a better understanding of the issues faced by geriatric patients with cancer, and to determine how much of a role nutrition plays in outcomes, Dr. Grant Williams, a geriatrician oncologist and assistant professor at the University of Alabama, Birmingham, worked with colleagues to create a patient-reported assessment tool that bridges the knowledge gap in this patient population.
Read More